CTRI Number |
CTRI/2018/02/011672 [Registered on: 02/02/2018] Trial Registered Retrospectively |
Last Modified On: |
26/01/2018 |
Post Graduate Thesis |
No |
Type of Trial |
Interventional |
Type of Study
|
Dentistry |
Study Design |
Other |
Public Title of Study
|
Comparative Clinical Evaluation of the Efficacy of Local Application of Ayapon Tablets Vs Sepgard Gel to Arrest Bleeding in Intraoral Open Wounds. |
Scientific Title of Study
|
Comparative Clinical Evaluation of the Efficacy of Local Application of AyaponTM Tablets Vs SepgardTM Gel to Arrest Bleeding in Intraoral Open Wounds. |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Abhishek singh |
Designation |
2nd year postgraduate student |
Affiliation |
Nair Hospital Dental College |
Address |
202,Department of periodontics,Nair hospital dental college,mumbai-08
Mumbai (Suburban) MAHARASHTRA 400067 India |
Phone |
9870611172 |
Fax |
|
Email |
abhisingh3005@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Mala dixit baburaj |
Designation |
Professor and Head of Department |
Affiliation |
Nair Hospital Dental College |
Address |
202,Department of periodontics,Nair hospital dental college,mumbai-08
Mumbai (Suburban) MAHARASHTRA 400067 India |
Phone |
9223340938 |
Fax |
|
Email |
maladixit25@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Abhishek singh |
Designation |
2nd year postgraduate student |
Affiliation |
Nair Hospital Dental College |
Address |
202,Department of periodontics,Nair hospital dental college,mumbai-08
Mumbai (Suburban) MAHARASHTRA 400067 India |
Phone |
9870611172 |
Fax |
|
Email |
abhisingh3005@gmail.com |
|
Source of Monetary or Material Support
|
Nair Hospital Dental College |
|
Primary Sponsor
|
Name |
Abhishek Singh |
Address |
A/503,Neelam Apartment,Sector-5,Charkop,Kandivali-west,Mumbai-67 |
Type of Sponsor |
Other [] |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Abhishek singh |
Nair hospital dental college |
Room No 202,Department of Periodontics,Nair Hospital Dental College,Mumbai central-08 Mumbai MAHARASHTRA |
9870611172
abhisingh3005@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional Ethics Committee - Nair Hospital Dental College |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
Patients undergoing any form of intraoral periodontal surgical therapy will be selected with similar bleeding parameters, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
Ayapon tablet |
Commercially available natural product like Ayapon tablet |
Comparator Agent |
Sepgard gel |
Commercially available synthetic product like Sepgard gel |
|
Inclusion Criteria
|
Age From |
20.00 Year(s) |
Age To |
45.00 Year(s) |
Gender |
Both |
Details |
1.Age group between 20-45years.
2.Patients in good systemic health.
3.Patients undergoing any form of intraoral periodontal surgical therapy will be selected with similar bleeding parameters. |
|
ExclusionCriteria |
Details |
1.Patients suffering from any systemic diseases or with compromised immune system.
2.Patients with a known history of drug allergy
3.Patients taking any drug known to cause gingival enlargement
4.Patients taking any immuno-suppressive drugs like corticosteroids.
5.Pregnant and/or lactating mothers.
6.Patients with any bleeding disorders.
7.Patient on anticoagulant therapy.
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
On-site computer system |
Blinding/Masking
|
Open Label |
Primary Outcome
|
Outcome |
TimePoints |
1)Bleeding test assessment.
2)Clotting time assessment.
|
During the Surgery bleeding time and clotting time will be assessed with the help of an automated timer |
|
Secondary Outcome
|
Outcome |
TimePoints |
During the surgery local application of Ayapon tablet and Sepgard gel has to be done to arrest bleeding. |
The patients will be recalled at 7th day,30th day,45th day post surgery to assess any untoward effect of these products on the recipient site. |
|
Target Sample Size
|
Total Sample Size="40" Sample Size from India="40"
Final Enrollment numbers achieved (Total)= "40"
Final Enrollment numbers achieved (India)="40" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
06/03/2017 |
Date of Study Completion (India) |
10/10/2017 |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Date Missing |
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Completed |
Publication Details
|
None Yet |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
The aim of this study is to clinically compare a natural product like
Ayapon tablet & a Synthetic product like Sepgard gel as an adjunct to
arrest bleeding to resolve inflammation thereby promote faster healing. A total of 40 patients will
be selected for this study from outpatient department of Periodontics, Nair
Hospital Dental College, Mumbai. Audio video consent will be taken prior to the
study and if the patient is willing to discontinue the treatment procedure during the study, he or she will be allowed to do so. In Group A Bleeding is arrested with local application of AyaponTM
tablet while in Group B Bleeding is arrested with application of SepgardTM gel. Computer generated randomization method will be used as sampling method. The duration of the study is 6 months. The primary efficacy parameters are bleeding and clotting time assessment. During the surgery local application of Ayapon tablet and Sepgard gel has to be done to arrest bleeding.The patients will be recalled at 7th day,30th day,45th day post surgery to assess any untoward effect of these products on the recipient site. The data will be analysed individually for all the patients. The values will be subjected comparison betweeen groups using unpaired student t-test. There is no conflict of interest. |